BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34034564)

  • 1. Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction.
    Chen F; Chen ZQ; Zhong GL; Zhu JJ
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1938-1947. PubMed ID: 34034564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
    Lei Q; Yi T; Chen C
    Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil.
    Su Q; Lv X; Sun Y; Ye Z; Kong B; Qin Z
    Biomed Pharmacother; 2018 Oct; 106():776-784. PubMed ID: 29990871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
    Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
    Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paeonol regulates NLRP3 inflammasomes and pyroptosis to alleviate spinal cord injury of rat.
    Zhao H; Wang X; Liu S; Zhang Q
    BMC Neurosci; 2022 Mar; 23(1):16. PubMed ID: 35303801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury.
    El-Sisi AEE; Sokar SS; Shebl AM; Mohamed DZ; Abu-Risha SE
    Toxicol Appl Pharmacol; 2021 Jan; 410():115340. PubMed ID: 33264646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panaxynol ameliorates cardiac ischemia/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1/TLR4/NF-κB axis.
    Ding HS; Huang Y; Qu JF; Wang YJ; Huang ZY; Wang FY; Yi WJ; Liu XX
    Int Immunopharmacol; 2023 Aug; 121():110222. PubMed ID: 37343367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF-
    Zhang X; Qu H; Yang T; Liu Q; Zhao D; Liu W; Wang T; Zhou H
    Evid Based Complement Alternat Med; 2022; 2022():5867987. PubMed ID: 35310035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
    Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protopine ameliorates OVA-induced asthma through modulatingTLR4/MyD88/NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis.
    Yang J; Zhang M; Luo Y; Xu F; Gao F; Sun Y; Yang B; Kuang H
    Phytomedicine; 2024 Apr; 126():155410. PubMed ID: 38367422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
    Yue RZ; Li YJ; Su BH; Li CJ; Zeng R
    BMC Nephrol; 2023 Feb; 24(1):25. PubMed ID: 36732683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis.
    Luan F; Lei Z; Peng X; Chen L; Peng L; Liu Y; Rao Z; Yang R; Zeng N
    Chem Biol Interact; 2022 Dec; 368():110245. PubMed ID: 36341777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway.
    Liu L; Zhou L; Wang L; Mao Z; Zheng P; Zhang F; Zhang H; Liu H
    Respir Res; 2023 Oct; 24(1):255. PubMed ID: 37880668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of tenascin-C attenuated cardiac injury by inactivating TLR4/NLRP3/caspase-1 pathway after myocardial infarction.
    Xu M; Ye Z; Zhao X; Guo H; Gong X; Huang R
    Cell Signal; 2021 Oct; 86():110084. PubMed ID: 34271086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil protects against coronary microembolization-induced myocardial injury by suppressing cardiomyocyte pyroptosis via the AMPK/TXNIP/NLRP3 signaling pathway.
    Liu Y; Shu J; Liu T; Xie J; Li T; Li H; Li L
    Eur J Pharmacol; 2022 Dec; 936():175365. PubMed ID: 36336011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin Exerts Cardioprotective Effects by Inhibiting NLRP3 Inflammasome-Induced Pyroptosis in Mice following Myocardial Infarction.
    Wen L; Wang M; Luo P; Meng X; Zhao M
    Oxid Med Cell Longev; 2021; 2021():5387799. PubMed ID: 34512865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
    Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
    Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats.
    Chen X; Li Y; Li J; Liu T; Jiang Q; Hong Y; Wang Q; Li C; Guo D; Wang Y
    J Ethnopharmacol; 2022 Mar; 285():114841. PubMed ID: 34793884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4/MyD88/NF-κB/NLRP3 pathway.
    Li HL; Li T; Chen ZQ; Li L
    Korean J Physiol Pharmacol; 2022 Sep; 26(5):335-345. PubMed ID: 36039734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.